In a previous case report [18], warfarin was used to prevent thromboembolism, and 81 mg of aspirin was administered to reduce PF4 activity, resulting in PF4 reduction to half its original value; however, the patient developed DVT while taking aspirin, and treatment was subsequently switched to DOAC, which improved clinical symptoms. This evidence concerns the gene PF4 and Thromboembolism.